-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports Sale of $4.33 Million in Common Shares

PUBT·11/06/2026 21:56:05
Listen to the news
United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports Sale of $4.33 Million in Common Shares
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 7,540 common shares on Nov. 5, 2026.
  • Rothblatt also exercised stock options for 9,500 common shares at $117.76 per share that day.
  • The transactions left the affected trust holdings at 326,403 common shares; directly owned common shares totaled 40,513.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000181), on November 06, 2026, and is solely responsible for the information contained therein.